These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 3777910)
1. Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci. Henry NK; Wilson WR; Roberts RB; Acar JF; Geraci JE Antimicrob Agents Chemother; 1986 Sep; 30(3):465-7. PubMed ID: 3777910 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis. Enzler MJ; Rouse MS; Henry NK; Geraci JE; Wilson WR J Infect Dis; 1987 May; 155(5):954-8. PubMed ID: 3644854 [TBL] [Abstract][Full Text] [Related]
3. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin. Gavaldà J; Pahissa A; Almirante B; Laguarda M; Crespo E; Pou L; Fernández F Antimicrob Agents Chemother; 1995 Sep; 39(9):2098-103. PubMed ID: 8540723 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci. Durack DT; Pelletier LL; Petersdorf RG J Clin Invest; 1974 Mar; 53(3):829-33. PubMed ID: 4492776 [TBL] [Abstract][Full Text] [Related]
5. Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci. Brandt CM; Warner CB; Rouse MS; Steckelberg JM; Wilson WR Antimicrob Agents Chemother; 1996 Dec; 40(12):2901-3. PubMed ID: 9124865 [TBL] [Abstract][Full Text] [Related]
6. Optimal aminoglycoside dosing regimen for penicillin-tobramycin synergism in experimental Streptococcus adjacens endocarditis. Saleh-Mghir A; Cremieux AC; Vallois JM; Muffat-Joly M; Devine C; Carbon C Antimicrob Agents Chemother; 1992 Nov; 36(11):2403-7. PubMed ID: 1489184 [TBL] [Abstract][Full Text] [Related]
7. Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis. Wright AJ; Wilson WR; Matsumoto JY; Washington JA; Geraci JE Antimicrob Agents Chemother; 1982 Dec; 22(6):972-5. PubMed ID: 6818902 [TBL] [Abstract][Full Text] [Related]
8. Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals. Wilson WR; Zak O; Sande MA J Infect Dis; 1985 Jun; 151(6):1028-33. PubMed ID: 3846608 [TBL] [Abstract][Full Text] [Related]
9. Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycin. Henry NK; Wilson WR; Geraci JE Antimicrob Agents Chemother; 1986 Nov; 30(5):725-8. PubMed ID: 3800348 [TBL] [Abstract][Full Text] [Related]
10. Treatment of streptococcal infective endocarditis. Wilson WR; Geraci JE Am J Med; 1985 Jun; 78(6B):128-37. PubMed ID: 3925771 [TBL] [Abstract][Full Text] [Related]
11. Experimental endocarditis in rabbits. 7. Results of long-term combined therapy of Streptococcus faecalis endocarditis with penicillin and gentamicin. Gutschik E Acta Pathol Microbiol Immunol Scand B; 1982 Aug; 90(4):295-302. PubMed ID: 6814183 [TBL] [Abstract][Full Text] [Related]
12. Endocarditis caused by nutritionally-variant streptococci: therapy with penicillin combined initially with gentamicin. Dworzack DL; Clark RB; Pugsley MP; Stanosheck JF; Dehning MM Nebr Med J; 1986 May; 71(5):118-21. PubMed ID: 3713907 [No Abstract] [Full Text] [Related]